Parkinsonís Institute and Berg Biomarker Collaboration Featured in this Monthís Drug Discovery News
 
Published Thursday, April 17, 2014 8:00 am
by Parkinson's Institute and Clinical Center

clientuploads/directory/News/Drug_Discovery_News_04_2014_caption.jpg

 

Birgitt Schuele, MD, Director of Gene Discovery and Stem Cell Modeling at the Parkinson’s Institute and Clinical Center and Niven R. Narian, Co-Founder, President, and Chief Technology Officer at Berg were recently interviewed by Drug Discovery News about our ongoing collaboration and first-of-its-kind approach to Parkinson’s disease biomarker discovery. 

Read the story featured in this month’s issue of Drug Discovery News. You can also view the story online and download a PDF of the entire April issue.

Stay connected with your Parkinson’s Institute:
eNews
Facebook
Twitter

 

 

Please Note: News Article is for educational and informational purposes only. Learn more about Clinical Trials and Clinical Studies at the Parkinson’s Institute here.


Send this page to a friend

Show Other Stories

675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)